Scroll to top

About us

Glialign was established in 2018 to take forward the work of UCL academics in engineering live neural tissue.

Our current project has been funded by the UCL Technology Fund, UK Innovation and Science: Seed Fund (UKI2S) and Innovate UK.

Our founders James Phillips and John Sinden are currently optimising a method for producing a living nerve growth guide designated “EngNT”, which is intended as an ‘off-the-shelf’ nerve replacement – primarily for peripheral nerve repair. This represents an innovative engineering solution to an unmet clinical need.


The technology behind our nerve replacement tissue

Read more


Access to scientific publications associated with our technology

Read more


Regular updates and news reports on our latest developments

Read more

Our team

The background behind the team at Glialign

Read more

Our latest news